U.S. flag

An official website of the United States government

GTR Home > Genes

MYCN MYCN proto-oncogene, bHLH transcription factor

Gene ID: 4613, updated on 3-Apr-2024
Gene type: protein coding
Also known as: NMYC; ODED; MODED; MPAPA; N-myc; FGLDS1; bHLHe37; MYCNsORF; MYCNsPEP

Summary

This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
A genome-wide association study identifies susceptibility loci for Wilms tumor.
GeneReviews: Not available
Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis.
GeneReviews: Not available
Feingold syndrome type 1
MedGen: C4551774OMIM: 164280GeneReviews: Feingold Syndrome 1
See labs
Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function.
GeneReviews: Not available
Megalencephaly-polydactyly syndrome
MedGen: CN377205OMIM: 620748GeneReviews: Not available
not available

Copy number response

Description
Copy number response
Triplosensitivity

No evidence available (Last evaluated 2017-07-12)

ClinGen Genome Curation Page
Haploinsufficency

Sufficient evidence for dosage pathogenicity (Last evaluated 2017-07-12)

ClinGen Genome Curation PagePubMed

Genomic context

Location:
2p24.3
Sequence:
Chromosome: 2; NC_000002.12 (15940550..15947004)
Total number of exons:
3

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.